Postgraduate Course

Course Directors: David J. Hass, MD, FACG, and Millie D. Long, MD, MPH, FACG

Attend this year’s Annual Postgraduate Course, “Practical Pearls for the Clinical Gastroenterologist – A Case-Based Approach” and gain practical takeaway points that you can implement in practice. Learn better ways to integrate the newest tools in diagnosis with the latest therapeutic/treatment alternatives to achieve optimal outcomes, improve your awareness and ability to incorporate patient care decision-making issues relating to common and not-so-common GI patient conditions, and enhance your overall capacity to frame effective disease management strategies in your practice.

Register for any two courses and save up to 10%!

Can’t join us in-person in Las Vegas?
Maximize your learning with one of our VIRTUAL All-Access Pass options and save 20%!

ACG All-Access Pass: The ACG All-Access Pass includes virtual-only access to the GI Pathophysiology Course, GI Pharmacology Course, Practice Management Summit, Postgraduate Course + Bonus Sessions (formerly Learning Luncheons), and the Annual Scientific Meeting + Bonus Sessions (formerly Breakfast Sessions). Registrants will also receive online access to the 2021 Self-Assessment Test.

NEW for 2021: ACG All-Access Pass + ASGE Endoscopy Course: The ACG All-Access Pass includes virtual-only access to all of the courses in the ACG All-Access Pass PLUS the ASGE Endoscopy Course.

Saturday, October 23, 2021 | All times are listed in the Pacific Time Zone
7:50 am Introduction by Course Directors
David J. Hass, MD, FACG, and Millie D. Long, MD, MPH, FACG
8:00 am Session 1A: Easing the Esophageal Enigma
Moderator: Nicholas J. Shaheen, MD, MPH, MACG
  • Esophageal Motility Disorders: Taming the Tube?
    Rena H. Yadlapati, MD, MSHS
    Provide an overview of esophageal motility disorders, with recommendations for updated management in 2021.
  • EoE – To Dilate or To Medicate?
    Evan S. Dellon, MD, MPH, FACG
    Describe current management strategies for EoE, from dietary management to medications, with an algorithm for practice.
  • Barrett’s Esophagus – Burn, Freeze, or Observe? Dysplasia Update
    Nicholas J. Shaheen, MD, MPH, MACG
    Provide an overview of screening, surveillance, and treatment of Barrett’s in 2021.
  • Management of Reflux: Effective Use of PPIs and Beyond
    Michael F. Vaezi, MD, PhD, MSc (Epi), FACG
    Describe a practical approach to the diagnosis and management of reflux, plus the role of and risks/benefits of PPIs, as well as treatment duration recommendations, and management of PPI-refractory patients.
  • Panel Q & A
9:40 am Break
10:20 am The David Sun Lecture – Colon Polyps: Going and Gone
Jerome D. Waye, MD, MACG
Introduced by: David A. Greenwald, MD, FACG, ACG President

Explain the history of colon polyps and what may happen in the future.
10:50 am Session 1B: Colonoscopy Pearls – Optimizing the Yield
Moderator: Douglas K. Rex, MD, MACG
  • Colorectal Cancer Screening and Surveillance – A Case-Based Approach and Guideline Review in 2021
    Aasma Shaukat, MD, MPH, FACG
    Provide an evidence-based approach for the practicing clinician on colon cancer screening and surveillance of polyps in 2021, including an update on the most recent ACG guidelines.
  • Optimal Polypectomy Techniques
    Douglas K. Rex, MD, MACG
    Identify best practices for visualization of polyps and for polypectomy to maximize completeness of resection.
  • Disparities in Colon Cancer Screening: How Do We Move the Needle?
    Darrell M. Gray, II, MD, MPH, FACG
    Assess ethnic/gender disparities in colon cancer screening and colon cancer outcomes, and implement a practical strategy for improved access to screening in practice.
  • Endoscopic and Non-Endoscopic Technologies for Colon Cancer Screening – What Lies Ahead of Us?
    Mark B. Pochapin, MD, FACG
    Review the recent and future technologies, both endoscopic and non-endoscopic, for colon cancer screening that will assist gastroenterologists now and in the future.
  • Panel Q & A
12:30 pm Lunch Break
2:00 pm Session 1C: Pancreatic Disease 101
Moderator: Timothy B. Gardner, MD, MS, FACG
  • Acute Pancreatitis – Common and Unusual Causes, and Optimal Management in 2021
    Timothy B. Gardner, MD, MS, FACG
    Review common and uncommon causes of acute pancreatitis, and optimal management based on current guidelines.
  • Pancreatic Cystic Lesions – When to Worry: Cases to Consider
    Linda S. Lee, MD, FACG
    Explain the different types of pancreatic cysts, their endoscopic, radiographic, and cytologic characteristics, and optimal management strategies.
  • Chronic Pancreatitis – Pearls in Pain Management
    Darwin L. Conwell, MD, MS, FACG
    Review the causes and natural history of chronic pancreatitis as well as best management strategies for treating chronic pain.
  • Panel Q & A
3:20 pm Break
4:00 pm Simultaneous Symposia
In-person attendees will have the opportunity to attend the symposium of their choice in Las Vegas. ACG will livestream one of the symposia for virtual attendees, and the remaining symposia will be available on-demand.


Symposium A: Women’s Health in IBD
Moderator: Sunanda V. Kane, MD, MSPH, FACG

  • Contraceptive and Pre-Conception Counseling in IBD by the Gastroenterologist
    Marla C. Dubinsky, MD
    Review contraceptive strategies for women with IBD, and appropriate pre-conception counseling from the gastroenterologist.
  • Management of IBD During Pregnancy: Implications for Mother and Baby
    Sunanda V. Kane, MD, MSPH, FACG
    Analyze strategies for management of IBD prior to, during, and post-pregnancy, including infant outcomes associated with advanced therapies.
  • Menopause and Beyond: The Older Adult With IBD
    Bharati Kochar, MD, MSCR
    Describe the physiologic changes with aging, the role of menopause in IBD, and considerations for management of the older adult with IBD.
  • Panel Q & A

Symposium B: A Focus on Clostridioides difficile
Moderator: Colleen R. Kelly, MD, FACG

  • Management of C. diff: Update on ACG Guidelines
    Colleen R. Kelly, MD, FACG
    Provide an overview of the ACG guidelines for the management of C. difficile enterocolitis.
  • C. diff in IBD: When to Escalate or De-Escalate IBD Therapy
    Jessica R. Allegretti, MD, MPH, FACG
    Outline strategies for management of C. difficile in IBD patients, including management of their IBD therapies.
  • Evolving Probiotic, Antibiotic, and Designer Transplant Therapies – Optimizing the Microbiome
    Paul Feuerstadt, MD, FACG
    Describe utilization of fecal transplant in practice, including an algorithmic approach and a guide to discussing the risks and benefits and modalities available (including considerations during the COVID era) to describe novel microbiome-based therapeutics for C. difficile.
  • Panel Q & A

Symposium C: The Latest Frontiers of Endoscopy
Moderator: Christopher C. Thompson, MD, MSc, FACG

  • ERCP – Tips for Difficult Cannulations/Special Populations
    Shivangi T. Kothari, MD, FACG
    Review the best practices for cannulation of the ampulla and approaches for special populations such as gastric bypass patients and pregnant patients.
  • POEM/ESD – Efficacy and Practicality: Cases to Behold
    Christopher C. Thompson, MD, MSc, FACG
    Review the role of POEM and ESD in the treatment of various GI luminal tract pathologies.
  • Endoscopic Management of Obesity
    Allison R. Schulman, MD, MPH
    Review the current state and evidence-based data of endoscopic obesity management.
  • Panel Q & A
5:15 pm Postgraduate Course Adjourns for the Day